Decreased Blood Flow after Sorafenib Administration Is an Imaging Biomarker to Predict Overall Survival in Patients with Advanced Hepatocellular Carcinoma

By  

Digestive Diseases, Vol. 32, Iss. 6, 2014-10 ,pp. : 733-739

Karger

Access to resources Recommend Favorite

Duration of Stable Disease Is Associated with Overall Survival in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib

By  

Digestive Diseases, Vol. 32, Iss. 6, 2014-10 ,pp. : 705-710

Karger

Access to resources Recommend Favorite

Monitoring C-reactive protein levels to predict favourable clinical outcomes from tocilizumab treatment in patients with rheumatoid arthritis

By Kojima Toshihisa   Yabe Yuichiro   Kaneko Atsushi   Hirano Yuji   Ishikawa Hisato   Hayashi Masatoshi   Miyake Hiroyuki   Takagi Hideki   Kato Takefumi   Terabe Kenya   Wanatabe Tsuyoshi   Tsuchiya Hiroki   Kida Daihei   Shioura Tomone   Funahashi Koji   Kato Daizo   Matsubara Hiroyuki   Takahashi Nobunori   Hattori Yosuke   Asai Nobuyuki   Ishiguro Naoki  

Modern Rheumatology, Vol. 23, Iss. 5, 2013-09 ,pp. : 977-985

Springer Publishing Company

Access to resources Recommend Favorite

Survival Benefit of Locoregional Treatment for Hepatocellular Carcinoma with Advanced Liver Cirrhosis

By  

Liver Cancer, Vol. 5, Iss. 3, 2016-05 ,pp. : 175-189

Karger

Access to resources Recommend Favorite

Addition of Local Hepatic Therapy to Sorafenib in Patients with Advanced Hepatocellular Carcinoma (Stage BCLC C)

By  

Digestion, Vol. 90, Iss. 4, 2014-12 ,pp. : 219-228

Karger

Access to resources Recommend Favorite